Atlas Trials

Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation

Clinical trial NCT04655391 · WITHDRAWN

Trial details

NCT number
NCT04655391
Sponsor
City of Hope Medical Center
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Acute Myeloid Leukemia
Start date
2022-06-25
Primary completion
2023-12-15
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.